<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02529085</url>
  </required_header>
  <id_info>
    <org_study_id>12 359 03</org_study_id>
    <nct_id>NCT02529085</nct_id>
  </id_info>
  <brief_title>PWS European Blood Bank for Infants and Controls From 0 to 48 Months</brief_title>
  <official_title>Study of Early Endocrine Profile in Infants With Prader-Willi Syndrome (PWS) in Order to Unravel the Switch From Early Feeding Difficulties to Obesity and Hyperphagia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Society for Paediatric Endocrinology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present project aims to determine the underlying mechanisms for the switch from failure&#xD;
      to thrive to excessive weight gain and hyperphagia with impaired satiety in PWS. The primary&#xD;
      objective is to describe the evolution of circulating hormones involved in feeding and&#xD;
      appetite regulation during the 4 first years of life. The secondary objective is to make this&#xD;
      blood bank available for other research projects and particularly the investigation of&#xD;
      hormones involved in hypogonadism.&#xD;
&#xD;
      Over the last ten years, the age at diagnosis in PWS has fallen significantly and the&#xD;
      majority of cases is now diagnosed during the 1st trimester of life giving the possibility to&#xD;
      collect precise clinical data and serum samples at early stages. The investigators of the&#xD;
      project are involved in the care of patients with PWS and have a devoted clinic and an&#xD;
      organized network in their country through clinical networks or patient associations.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators propose to perform a prospective multicentric study, both longitudinal&#xD;
      (duration 30 months) and cross-sectional with implementation of a blood bank in link with a&#xD;
      multicenter database including clinical data on birth, auxology, endocrine functions and&#xD;
      feeding behaviour. The cohort will include 200 infants from 3 to 48 months with PWS and 200&#xD;
      controls matched on age recruited in the 6 participating countries. The investigators make&#xD;
      the assumption that 3 blood sampling will be necessary during the first year and 6 monthly&#xD;
      sampling thereafter. For measuring hormones and neuropeptides (ghrelin, insulin, leptin,&#xD;
      pancreatic polypeptide, oxytocin, cortisol, melatonin, orexin A, GLP-1 and PYY) involved in&#xD;
      feeding and appetite regulation the investigators will use primarily multiplex microplates&#xD;
      technics requiring 50-200µl of sample. Intragroup and intergroup comparisons will be&#xD;
      performed in order to describe the evolution of each hormone with time and to compare data&#xD;
      obtained in the PWS group with those obtained in the control group.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2013</start_date>
  <completion_date type="Actual">June 1, 2017</completion_date>
  <primary_completion_date type="Actual">June 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Levels of hormones and neuropeptides</measure>
    <time_frame>42 months</time_frame>
    <description>Measure of hormones and neuropeptides (ghrelin, insulin, leptin, pancreatic polypeptide, oxytocin, melatonin, orexins) involved in feeding and appetite regulation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation between hormones and neuropeptides levels</measure>
    <time_frame>42 months</time_frame>
    <description>study the correlation between ghrelin, insulin, leptin, pancreatic polypeptide, oxytocin, melatonin, orexins</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">215</enrollment>
  <condition>Prader-Willi Syndrome</condition>
  <arm_group>
    <arm_group_label>Infants with PWS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blood samples for the bank in link with a multicenter database including clinical data on birth, auxology, endocrine functions and feeding behaviour</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Blood samples for the bank in children hospitalized for a planned surgery for malformation, orthopaedic or visceral surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood samples</intervention_name>
    <description>blood samples for the bank</description>
    <arm_group_label>Infants with PWS</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (PWS infants cohort)&#xD;
&#xD;
          -  Genetic diagnosis of Prader-Willi syndrome&#xD;
&#xD;
        Exclusion Criteria (PWS infants cohort)&#xD;
&#xD;
          -  none&#xD;
&#xD;
        Inclusion Criteria (control group)&#xD;
&#xD;
          -  children hospitalized for a planned surgery for malformation, orthopaedic or visceral&#xD;
             surgery&#xD;
&#xD;
        Exclusion Criteria (control group)&#xD;
&#xD;
          -  children with endocrine disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maithe TAUBER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Unité d'Endocrinologie Pédiatrique / Université Catholique de Louvain</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Pediatrics / Division of Endocrinology</name>
      <address>
        <city>Toulouse</city>
        <state>Haute-Garonne</state>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Endocrinology / University Children's Hospital</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Pediatrics / Division of Endocrinology / Erasmus University Medical Center / Sophia Children's Hospital Rotterdam</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015 GJ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Metabolic &amp; Molecular Imaging Group / MRC Clinical Sciences Centre / Imperial College London / Hammersmith Hospital</name>
      <address>
        <city>London</city>
        <zip>W12 0NN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Cadoudal T, Buléon M, Sengenès C, Diene G, Desneulin F, Molinas C, Eddiry S, Conte-Auriol F, Daviaud D, Martin PG, Bouloumié A, Salles JP, Tauber M, Valet P. Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment. Int J Obes (Lond). 2014 Sep;38(9):1234-40. doi: 10.1038/ijo.2014.3. Epub 2014 Jan 10.</citation>
    <PMID>24406482</PMID>
  </reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>April 24, 2015</study_first_submitted>
  <study_first_submitted_qc>August 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2015</study_first_posted>
  <last_update_submitted>November 10, 2020</last_update_submitted>
  <last_update_submitted_qc>November 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prader-Willi Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

